{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T14:40:10Z","timestamp":1744296010356,"version":"3.40.4"},"reference-count":100,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,4,10]]},"DOI":"10.7759\/cureus.82008","type":"journal-article","created":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T14:02:31Z","timestamp":1744293751000},"source":"Crossref","is-referenced-by-count":0,"title":["Systemic Sclerosis and Primary Biliary Cholangitis: A Comprehensive Review of Two Overlapping Rare Entities With Insights on Diagnostics and Management"],"prefix":"10.7759","author":[{"given":"Hemang H","family":"Thakkar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nissy V","family":"Mathew","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Etikala P","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anusha L","family":"Cheetiyar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Varun","family":"Kommalapati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aksa","family":"Mathew","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abirami","family":"Rajendiran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raina","family":"Riyaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nixon","family":"Joseph","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdullah H","family":"Obadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nazmi","family":"Vahora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariam","family":"Alamgir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hossam T","family":"Ali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1111\/cei.13588","article-title":"Investigation of immune complexes formed by mitochondrial antigens containing a new lipoylated site in sera of primary biliary cholangitis patients","volume":"204","author":"Aibara N","year":"2021","unstructured":"Aibara N, Ohyama K, Nakamura M, et al.. Investigation of immune complexes formed by mitochondrial antigens containing a new lipoylated site in sera of primary biliary cholangitis patients. Clin Exp Immunol. 2021, 204:335-43. 10.1111\/cei.13588","journal-title":"Clin Exp Immunol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(24)01303-5","article-title":"Primary biliary cholangitis","volume":"404","author":"Tanaka A","year":"2024","unstructured":"Tanaka A, Ma X, Takahashi A, Vierling JM. Primary biliary cholangitis. Lancet. 2024, 404:1053-66. 10.1016\/S0140-6736(24)01303-5","journal-title":"Lancet"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.090340","article-title":"Primary biliary cirrhosis (PBC), PBC autoantibodies, and hepatic parameter abnormalities in a large population of systemic sclerosis patients","volume":"36","author":"Assassi S","year":"2009","unstructured":"Assassi S, Fritzler MJ, Arnett FC, et al.. Primary biliary cirrhosis (PBC), PBC autoantibodies, and hepatic parameter abnormalities in a large population of systemic sclerosis patients. J Rheumatol. 2009, 36:2250-6. 10.3899\/jrheum.090340","journal-title":"J Rheumatol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-3-1","article-title":"Primary biliary cirrhosis","volume":"3","author":"Kumagi T","year":"2008","unstructured":"Kumagi T, Heathcote EJ. Primary biliary cirrhosis. Orphanet J Rare Dis. 2008, 3:1. 10.1186\/1750-1172-3-1","journal-title":"Orphanet J Rare Dis"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2024.103289","article-title":"Epidemiologic and genetic associations between primary biliary cholangitis and extrahepatic rheumatic diseases","volume":"148","author":"Qian Q","year":"2024","unstructured":"Qian Q, Wu Y, Cui N, et al.. Epidemiologic and genetic associations between primary biliary cholangitis and extrahepatic rheumatic diseases. J Autoimmun. 2024, 148:103289. 10.1016\/j.jaut.2024.103289","journal-title":"J Autoimmun"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1093\/cei\/uxad012","article-title":"Systemic sclerosis and primary biliary cholangitis share an antibody population with identical specificity","volume":"212","author":"Favoino E","year":"2023","unstructured":"Favoino E, Grapsi E, Barbuti G, et al.. Systemic sclerosis and primary biliary cholangitis share an antibody population with identical specificity. Clin Exp Immunol. 2023, 212:32-8. 10.1093\/cei\/uxad012","journal-title":"Clin Exp Immunol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2021.102842","article-title":"Primary biliary cholangitis and systemic sclerosis (Reynolds syndrome): a case-control study","volume":"20","author":"David C","year":"2021","unstructured":"David C, Chaigne B, Hollande C, et al.. Primary biliary cholangitis and systemic sclerosis (Reynolds syndrome): a case-control study. Autoimmun Rev. 2021, 20:102842. 10.1016\/j.autrev.2021.102842","journal-title":"Autoimmun Rev"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1097\/MEG.0b013e328350f95b","article-title":"Autoimmune hepatitis\/primary biliary cirrhosis overlap syndrome and associated extrahepatic autoimmune diseases","volume":"24","author":"Efe C","year":"2012","unstructured":"Efe C, Wahlin S, Ozaslan E, et al.. Autoimmune hepatitis\/primary biliary cirrhosis overlap syndrome and associated extrahepatic autoimmune diseases. Eur J Gastroenterol Hepatol. 2012, 24:531-4. 10.1097\/MEG.0b013e328350f95b","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.160243","article-title":"Prevalence of systemic sclerosis in primary biliary cholangitis using the new ACR\/EULAR classification criteria","volume":"44","author":"Zheng B","year":"2017","unstructured":"Zheng B, Vincent C, Fritzler MJ, Sen\u00e9cal JL, Koenig M, Joyal F. Prevalence of systemic sclerosis in primary biliary cholangitis using the new ACR\/EULAR classification criteria. J Rheumatol. 2017, 44:33-9. 10.3899\/jrheum.160243","journal-title":"J Rheumatol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.15329","article-title":"Regional variation and temporal trend of primary biliary cholangitis epidemiology: a systematic review and meta-analysis","volume":"36","author":"Lv T","year":"2021","unstructured":"Lv T, Chen S, Li M, Zhang D, Kong Y, Jia J. Regional variation and temporal trend of primary biliary cholangitis epidemiology: a systematic review and meta-analysis. J Gastroenterol Hepatol. 2021, 36:1423-34. 10.1111\/jgh.15329","journal-title":"J Gastroenterol Hepatol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1186\/s12876-024-03319-3","article-title":"Primary biliary cholangitis has causal effects on systemic rheumatic diseases: a Mendelian randomization study","volume":"24","author":"Zhang HP","year":"2024","unstructured":"Zhang HP, Zhou Z, Chen K, Xiong LF, Wu J, Jin L. Primary biliary cholangitis has causal effects on systemic rheumatic diseases: a Mendelian randomization study. BMC Gastroenterol. 2024, 24:294. 10.1186\/s12876-024-03319-3","journal-title":"BMC Gastroenterol"},{"key":"ref12","article-title":"Systemic sclerosis associated with primary biliary cirrhosis (Reynolds\u2019 syndrome) in a pair of siblings","volume":"25","author":"Jakez-Ocampo J","year":"2007","unstructured":"Jakez-Ocampo J, Atisha-Fregoso Y, Llorente L. Systemic sclerosis associated with primary biliary cirrhosis (Reynolds\u2019 syndrome) in a pair of siblings. Clin Exp Rheumatol. 2007, 25:0793.","journal-title":"Clin Exp Rheumatol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2023.109267","article-title":"Global, regional, and national incidence and prevalence of systemic sclerosis","volume":"248","author":"Tian J","year":"2023","unstructured":"Tian J, Kang S, Zhang D, et al.. Global, regional, and national incidence and prevalence of systemic sclerosis. Clin Immunol. 2023, 248:109267. 10.1016\/j.clim.2023.109267","journal-title":"Clin Immunol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.1995.tb06646.x","article-title":"Anti-M4 antibodies measured by a sulphite oxidase ELISA in patients with both anti-centromere and anti-M2 antibodies","volume":"102","author":"Bunn CC","year":"1995","unstructured":"Bunn CC, McMorrow M. Anti-M4 antibodies measured by a sulphite oxidase ELISA in patients with both anti-centromere and anti-M2 antibodies. Clin Exp Immunol. 1995, 102:131-6. 10.1111\/j.1365-2249.1995.tb06646.x","journal-title":"Clin Exp Immunol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1515\/cclm-2019-0655","article-title":"Evaluation of the primary biliary cholangitis-related serologic profile in a large cohort of Belgian systemic sclerosis patients","volume":"58","author":"Florin L","year":"2020","unstructured":"Florin L, Rubben K, Vanhaecke A, Devreese K, De Keyser F, Smith V, Bonroy C. Evaluation of the primary biliary cholangitis-related serologic profile in a large cohort of Belgian systemic sclerosis patients. Clin Chem Lab Med. 2020, 58:416-23. 10.1515\/cclm-2019-0655","journal-title":"Clin Chem Lab Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/2608605","article-title":"The histone modification code in the pathogenesis of autoimmune diseases","volume":"2017","author":"Araki Y","year":"2017","unstructured":"Araki Y, Mimura T. The histone modification code in the pathogenesis of autoimmune diseases. Mediators Inflamm. 2017, 2017:2608605. 10.1155\/2017\/2608605","journal-title":"Mediators Inflamm"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.1998.tb00758.x","article-title":"Immunological features of patients with primary biliary cirrhosis (PBC) overlapping systemic sclerosis: a comparison with patients with PBC alone","volume":"13","author":"Akimoto S","year":"1998","unstructured":"Akimoto S, Ishikawa O, Takagi H, Miyachi Y. Immunological features of patients with primary biliary cirrhosis (PBC) overlapping systemic sclerosis: a comparison with patients with PBC alone. J Gastroenterol Hepatol. 1998, 13:897-901. 10.1111\/j.1440-1746.1998.tb00758.x","journal-title":"J Gastroenterol Hepatol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-015-0572-y","article-title":"Identification of NF-\u03baB and PLCL2 as new susceptibility genes and highlights on a potential role of IRF8 through interferon signature modulation in systemic sclerosis","volume":"17","author":"Arismendi M","year":"2015","unstructured":"Arismendi M, Giraud M, Ruzehaji N, et al.. Identification of NF-\u03baB and PLCL2 as new susceptibility genes and highlights on a potential role of IRF8 through interferon signature modulation in systemic sclerosis. Arthritis Res Ther. 2015, 17:71. 10.1186\/s13075-015-0572-y","journal-title":"Arthritis Res Ther"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1001\/jama.291.9.1127","article-title":"Microchimerism: an investigative frontier in autoimmunity and transplantation","volume":"291","author":"Adams KM","year":"2004","unstructured":"Adams KM, Nelson JL. Microchimerism: an investigative frontier in autoimmunity and transplantation. JAMA. 2004, 291:1127-31. 10.1001\/jama.291.9.1127","journal-title":"JAMA"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1164202","article-title":"Primary biliary cholangitis: molecular pathogenesis perspectives and therapeutic potential of natural products","volume":"14","author":"Zhao Y","year":"2023","unstructured":"Zhao Y, Wei S, Chen L, Zhou X, Ma X. Primary biliary cholangitis: molecular pathogenesis perspectives and therapeutic potential of natural products. Front Immunol. 2023, 14:1164202. 10.3389\/fimmu.2023.1164202","journal-title":"Front Immunol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.5009\/gnl16365","article-title":"Extrahepatic manifestations of primary biliary cholangitis","volume":"11","author":"Chalifoux SL","year":"2017","unstructured":"Chalifoux SL, Konyn PG, Choi G, Saab S. Extrahepatic manifestations of primary biliary cholangitis. Gut Liver. 2017, 11:771-80. 10.5009\/gnl16365","journal-title":"Gut Liver"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1111\/j.1346-8138.1999.tb03503.x","article-title":"Clinical and immunological characterization of patients with systemic sclerosis overlapping primary biliary cirrhosis: a comparison with patients with systemic sclerosis alone","volume":"26","author":"Akimoto S","year":"1999","unstructured":"Akimoto S, Ishikawa O, Muro Y, Takagi H, Tamura T, Miyachi Y. Clinical and immunological characterization of patients with systemic sclerosis overlapping primary biliary cirrhosis: a comparison with patients with systemic sclerosis alone. J Dermatol. 1999, 26:18-22. 10.1111\/j.1346-8138.1999.tb03503.x","journal-title":"J Dermatol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.110167","article-title":"Primary biliary cirrhosis-related autoantibodies in a large cohort of Italian patients with systemic sclerosis","volume":"38","author":"Cavazzana I","year":"2011","unstructured":"Cavazzana I, Ceribelli A, Taraborelli M, et al.. Primary biliary cirrhosis-related autoantibodies in a large cohort of Italian patients with systemic sclerosis. J Rheumatol. 2011, 38:2180-5. 10.3899\/jrheum.110167","journal-title":"J Rheumatol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10010163","article-title":"Systemic sclerosis: from pathophysiology to novel therapeutic approaches","volume":"10","author":"Benfaremo D","year":"2022","unstructured":"Benfaremo D, Svegliati S, Paolini C, Agarbati S, Moroncini G. Systemic sclerosis: from pathophysiology to novel therapeutic approaches. Biomedicines. 2022, 10:163. 10.3390\/biomedicines10010163","journal-title":"Biomedicines"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241814287","article-title":"The pathogenesis of systemic sclerosis: the origin of fibrosis and interlink with vasculopathy and autoimmunity","volume":"24","author":"Ko J","year":"2023","unstructured":"Ko J, Noviani M, Chellamuthu VR, Albani S, Low AH. The pathogenesis of systemic sclerosis: the origin of fibrosis and interlink with vasculopathy and autoimmunity. Int J Mol Sci. 2023, 24:14287. 10.3390\/ijms241814287","journal-title":"Int J Mol Sci"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01136","article-title":"Mucosal-associated invariant T cells develop an innate-like transcriptomic program in anti-mycobacterial responses","volume":"11","author":"Sharma M","year":"2020","unstructured":"Sharma M, Zhang S, Niu L, Lewinsohn DM, Zhang X, Huang S. Mucosal-associated invariant T cells develop an innate-like transcriptomic program in anti-mycobacterial responses. Front Immunol. 2020, 11:1136. 10.3389\/fimmu.2020.01136","journal-title":"Front Immunol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2012.05.004","article-title":"Th17 and regulatory T lymphocytes in primary biliary cirrhosis and systemic sclerosis as models of autoimmune fibrotic diseases","volume":"12","author":"Fenoglio D","year":"2012","unstructured":"Fenoglio D, Bernuzzi F, Battaglia F, et al.. Th17 and regulatory T lymphocytes in primary biliary cirrhosis and systemic sclerosis as models of autoimmune fibrotic diseases. Autoimmun Rev. 2012, 12:300-4. 10.1016\/j.autrev.2012.05.004","journal-title":"Autoimmun Rev"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.coche.2017.11.006","article-title":"CD8+ T cells and NK cells: parallel and complementary soldiers of immunotherapy","volume":"19","author":"Rosenberg J","year":"2018","unstructured":"Rosenberg J, Huang J. CD8+ T cells and NK cells: parallel and complementary soldiers of immunotherapy. Curr Opin Chem Eng. 2018, 19:9-20. 10.1016\/j.coche.2017.11.006","journal-title":"Curr Opin Chem Eng"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-62509-x","article-title":"Dissecting causal relationships between primary biliary cholangitis and extrahepatic autoimmune diseases based on Mendelian randomization","volume":"14","author":"Ma G","year":"2024","unstructured":"Ma G, Yang J, Wang X, et al.. Dissecting causal relationships between primary biliary cholangitis and extrahepatic autoimmune diseases based on Mendelian randomization. Sci Rep. 2024, 14:11528. 10.1038\/s41598-024-62509-x","journal-title":"Sci Rep"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1177\/2397198318802763","article-title":"Systemic sclerosis and primary biliary cholangitis: an overlapping entity?","volume":"4","author":"Lepri G","year":"2019","unstructured":"Lepri G, Bellando Randone S, Matucci Cerinic M, Allanore Y. Systemic sclerosis and primary biliary cholangitis: an overlapping entity?. J Scleroderma Relat Disord. 2019, 4:111-7. 10.1177\/2397198318802763","journal-title":"J Scleroderma Relat Disord"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1038\/gene.2011.89","article-title":"Association of primary biliary cirrhosis with variants in the CLEC16A, SOCS1, SPIB and SIAE immunomodulatory genes","volume":"13","author":"Hirschfield GM","year":"2012","unstructured":"Hirschfield GM, Xie G, Lu E, et al.. Association of primary biliary cirrhosis with variants in the CLEC16A, SOCS1, SPIB and SIAE immunomodulatory genes. Genes Immun. 2012, 13:328-35. 10.1038\/gene.2011.89","journal-title":"Genes Immun"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1038\/ng.631","article-title":"Variants at IRF5-TNPO3, 17q12-21 and MMEL1 are associated with primary biliary cirrhosis","volume":"42","author":"Hirschfield GM","year":"2010","unstructured":"Hirschfield GM, Liu X, Han Y, et al.. Variants at IRF5-TNPO3, 17q12-21 and MMEL1 are associated with primary biliary cirrhosis. Nat Genet. 2010, 42:655-7. 10.1038\/ng.631","journal-title":"Nat Genet"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0810440","article-title":"Primary biliary cirrhosis associated with HLA, IL12A, and IL12RB2 variants","volume":"360","author":"Hirschfield GM","year":"2009","unstructured":"Hirschfield GM, Liu X, Xu C, et al.. Primary biliary cirrhosis associated with HLA, IL12A, and IL12RB2 variants. N Engl J Med. 2009, 360:2544-55. 10.1056\/NEJMoa0810440","journal-title":"N Engl J Med"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2021.04.055","article-title":"An international genome-wide meta-analysis of primary biliary cholangitis: novel risk loci and candidate drugs","volume":"75","author":"Cordell HJ","year":"2021","unstructured":"Cordell HJ, Fryett JJ, Ueno K, et al.. An international genome-wide meta-analysis of primary biliary cholangitis: novel risk loci and candidate drugs. J Hepatol. 2021, 75:572-81. 10.1016\/j.jhep.2021.04.055","journal-title":"J Hepatol"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmg.2021.104292","article-title":"The genetic architecture of primary biliary cholangitis","volume":"64","author":"Gerussi A","year":"2021","unstructured":"Gerussi A, Carbone M, Corpechot C, Schramm C, Asselta R, Invernizzi P. The genetic architecture of primary biliary cholangitis. Eur J Med Genet. 2021, 64:104292. 10.1016\/j.ejmg.2021.104292","journal-title":"Eur J Med Genet"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(200106)44:6<1359::AID-ART228>3.0.CO;2-S","article-title":"Familial occurrence frequencies and relative risks for systemic sclerosis (scleroderma) in three United States cohorts","volume":"44","author":"Arnett FC","year":"2001","unstructured":"Arnett FC, Cho M, Chatterjee S, Aguilar MB, Reveille JD, Mayes MD. Familial occurrence frequencies and relative risks for systemic sclerosis (scleroderma) in three United States cohorts. Arthritis Rheum. 2001, 44:1359-62. 10.1002\/1529-0131(200106)44:6&lt;1359::AID-ART228&gt;3.0.CO;2-S","journal-title":"Arthritis Rheum"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1002\/art.22647","article-title":"Clinical, immunologic, and genetic features of familial systemic sclerosis","volume":"56","author":"Assassi S","year":"2007","unstructured":"Assassi S, Arnett FC, Reveille JD, Gourh P, Mayes MD. Clinical, immunologic, and genetic features of familial systemic sclerosis. Arthritis Rheum. 2007, 56:2031-7. 10.1002\/art.22647","journal-title":"Arthritis Rheum"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1002\/art.30171","article-title":"Inactivation of the transcription factor STAT-4 prevents inflammation-driven fibrosis in animal models of systemic sclerosis","volume":"63","author":"Avouac J","year":"2011","unstructured":"Avouac J, F\u00fcrnrohr BG, Tomcik M, et al.. Inactivation of the transcription factor STAT-4 prevents inflammation-driven fibrosis in animal models of systemic sclerosis. Arthritis Rheum. 2011, 63:800-9. 10.1002\/art.30171","journal-title":"Arthritis Rheum"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1586\/eci.11.31","article-title":"Targeting STAT4 in systemic sclerosis: a promising new direction","volume":"7","author":"Barnes J","year":"2011","unstructured":"Barnes J, Agarwal SK. Targeting STAT4 in systemic sclerosis: a promising new direction. Expert Rev Clin Immunol. 2011, 7:445-8. 10.1586\/eci.11.31","journal-title":"Expert Rev Clin Immunol"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2015-208154","article-title":"Influence of TYK2 in systemic sclerosis susceptibility: a new locus in the IL-12 pathway","volume":"75","author":"L\u00f3pez-Isac E","year":"2016","unstructured":"L\u00f3pez-Isac E, Campillo-Davo D, Bossini-Castillo L, et al.. Influence of TYK2 in systemic sclerosis susceptibility: a new locus in the IL-12 pathway. Ann Rheum Dis. 2016, 75:1521-6. 10.1136\/annrheumdis-2015-208154","journal-title":"Ann Rheum Dis"},{"key":"ref41","article-title":"Transcriptional activity of nuclear factor \u03bab family genes in patients with systemic sclerosis","volume":"47","author":"Lis-\u015awi\u0119ty A","year":"2017","unstructured":"Lis-\u015awi\u0119ty A, Gola J, Mazurek U, Brzezi\u0144ska-Wcis\u0142o L. Transcriptional activity of nuclear factor \u03bab family genes in patients with systemic sclerosis. Ann Clin Lab Sci. 2017, 47:306-9.","journal-title":"Ann Clin Lab Sci"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1172\/JCI115974","article-title":"Association of amino acid sequences in the HLA-DQB1 first domain with antitopoisomerase I autoantibody response in scleroderma (progressive systemic sclerosis)","volume":"90","author":"Reveille JD","year":"1992","unstructured":"Reveille JD, Durban E, MacLeod-St Clair MJ, Goldstein R, Moreda R, Altman RD, Arnett FC. Association of amino acid sequences in the HLA-DQB1 first domain with antitopoisomerase I autoantibody response in scleroderma (progressive systemic sclerosis). J Clin Invest. 1992, 90:973-80. 10.1172\/JCI115974","journal-title":"J Clin Invest"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1038\/ng.565","article-title":"Genome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locus","volume":"42","author":"Radstake TR","year":"2010","unstructured":"Radstake TR, Gorlova O, Rueda B, et al.. Genome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locus. Nat Genet. 2010, 42:426-9. 10.1038\/ng.565","journal-title":"Nat Genet"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1002\/art.23601","article-title":"The PTPN22 620W allele confers susceptibility to systemic sclerosis: findings of a large case-control study of European Caucasians and a meta-analysis","volume":"58","author":"Dieud\u00e9 P","year":"2008","unstructured":"Dieud\u00e9 P, Guedj M, Wipff J, et al.. The PTPN22 620W allele confers susceptibility to systemic sclerosis: findings of a large case-control study of European Caucasians and a meta-analysis. Arthritis Rheum. 2008, 58:2183-8. 10.1002\/art.23601","journal-title":"Arthritis Rheum"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-017-1253-9","article-title":"Characterization of the HLA-DR\u03b21 third hypervariable region amino acid sequence according to charge and parental inheritance in systemic sclerosis","volume":"19","author":"Gentil CA","year":"2017","unstructured":"Gentil CA, Gammill HS, Luu CT, Mayes MD, Furst DE, Nelson JL. Characterization of the HLA-DR\u03b21 third hypervariable region amino acid sequence according to charge and parental inheritance in systemic sclerosis. Arthritis Res Ther. 2017, 19:46. 10.1186\/s13075-017-1253-9","journal-title":"Arthritis Res Ther"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1002341","article-title":"Association of NCF2, IKZF1, IRF8, IFIH1, and TYK2 with systemic lupus erythematosus","volume":"7","author":"Cunninghame Graham DS","year":"2011","unstructured":"Cunninghame Graham DS, Morris DL, Bhangale TR, et al.. Association of NCF2, IKZF1, IRF8, IFIH1, and TYK2 with systemic lupus erythematosus. PLoS Genet. 2011, 7:e1002341. 10.1371\/journal.pgen.1002341","journal-title":"PLoS Genet"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajhg.2013.12.002","article-title":"Immunochip analysis identifies multiple susceptibility loci for systemic sclerosis","volume":"94","author":"Mayes MD","year":"2014","unstructured":"Mayes MD, Bossini-Castillo L, Gorlova O, et al.. Immunochip analysis identifies multiple susceptibility loci for systemic sclerosis. Am J Hum Genet. 2014, 94:47-61. 10.1016\/j.ajhg.2013.12.002","journal-title":"Am J Hum Genet"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/976427","article-title":"Primary biliary cirrhosis associated with systemic sclerosis: diagnostic and clinical challenges","volume":"2011","author":"Rigamonti C","year":"2011","unstructured":"Rigamonti C, Bogdanos DP, Mytilinaiou MG, Smyk DS, Rigopoulou EI, Burroughs AK. Primary biliary cirrhosis associated with systemic sclerosis: diagnostic and clinical challenges. Int J Rheumatol. 2011, 2011:976427. 10.1155\/2011\/976427","journal-title":"Int J Rheumatol"},{"key":"ref49","article-title":"Primary biliary cirrhosis and scleroderma complicated by Barrett\u2019s oesophagus: a case report","volume":"79","author":"Chang CP","year":"1991","unstructured":"Chang CP, Huang YS, Tsay SH, Lai KH, Lee SD. Primary biliary cirrhosis and scleroderma complicated by Barrett\u2019s oesophagus: a case report. South Africa Med J. 1991, 79:397-8.","journal-title":"South Africa Med J"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(82)90178-4","article-title":"Immune complexes in primary biliary cirrhosis. Higher prevalence of circulating immune complexes in patients with associated autoimmune features","volume":"73","author":"Gupta RC","year":"1982","unstructured":"Gupta RC, Dickson ER, McDuffie FC, Baggenstoss AH. Immune complexes in primary biliary cirrhosis. Higher prevalence of circulating immune complexes in patients with associated autoimmune features. Am J Med. 1982, 73:192-8. 10.1016\/0002-9343(82)90178-4","journal-title":"Am J Med"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.4021\/jmc276w","article-title":"A case of Reynolds syndrome: scleroderma and primary biliary cirrhosis overlap syndrome","volume":"2","author":"Simoes N","year":"2011","unstructured":"Simoes N, Alves P, Esperto H, Barbosa B, Santos L, Costa J. A case of Reynolds syndrome: scleroderma and primary biliary cirrhosis overlap syndrome. J Med Case. 2011, 2:225-8. 10.4021\/jmc276w","journal-title":"J Med Case"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.49.3457","article-title":"Sarcoidosis in a patient with systemic sclerosis and primary biliary cirrhosis","volume":"49","author":"Sakamoto N","year":"2010","unstructured":"Sakamoto N, Ishimatsu Y, Kakugawa T, et al.. Sarcoidosis in a patient with systemic sclerosis and primary biliary cirrhosis. Intern Med. 2010, 49:1609-11. 10.2169\/internalmedicine.49.3457","journal-title":"Intern Med"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1186\/s13256-015-0747-9","article-title":"Primary sclerosing cholangitis associated with CREST (calcinosis, Raynaud phenomenon, oesophageal dysmotility, sclerodactyly and telangiectasia) in an elderly woman: a case report","volume":"9","author":"Powell A","year":"2015","unstructured":"Powell A, McNeil J. Primary sclerosing cholangitis associated with CREST (calcinosis, Raynaud phenomenon, oesophageal dysmotility, sclerodactyly and telangiectasia) in an elderly woman: a case report. J Med Case Rep. 2015, 9:272. 10.1186\/s13256-015-0747-9","journal-title":"J Med Case Rep"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2249.1998.00655.x","article-title":"Autoantibodies to C-reactive protein (CRP) and other acute-phase proteins in systemic autoimmune diseases","volume":"113","author":"Bell SA","year":"1998","unstructured":"Bell SA, Faust H, Schmid A, Meurer M. Autoantibodies to C-reactive protein (CRP) and other acute-phase proteins in systemic autoimmune diseases. Clin Exp Immunol. 1998, 113:327-32. 10.1046\/j.1365-2249.1998.00655.x","journal-title":"Clin Exp Immunol"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.1990.tb03325.x","article-title":"Autoantibodies to mitochondrial and centromere antigens in primary biliary cirrhosis and systemic sclerosis","volume":"81","author":"McHugh NJ","year":"1990","unstructured":"McHugh NJ, James IE, Fairburn K, Maddison PJ. Autoantibodies to mitochondrial and centromere antigens in primary biliary cirrhosis and systemic sclerosis. Clin Exp Immunol. 1990, 81:244-9. 10.1111\/j.1365-2249.1990.tb03325.x","journal-title":"Clin Exp Immunol"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.5021\/ad.2020.32.1.69","article-title":"Diffuse systemic sclerosis in a patient with primary biliary cirrhosis and autoimmune hepatitis overlap syndrome: a case report","volume":"32","author":"Han HS","year":"2020","unstructured":"Han HS, Ahn GR, Kim HJ, Park KY, Li K, Seo SJ. Diffuse systemic sclerosis in a patient with primary biliary cirrhosis and autoimmune hepatitis overlap syndrome: a case report. Ann Dermatol. 2020, 32:69-73. 10.5021\/ad.2020.32.1.69","journal-title":"Ann Dermatol"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-005-0178-x","article-title":"Primary biliary cirrhosis (PBC)-CREST overlap syndrome with coexistence of Sj\u00f6gren's syndrome and thyroid dysfunction","volume":"26","author":"Nakamura T","year":"2007","unstructured":"Nakamura T, Higashi S, Tomoda K, Tsukano M, Sugi K. Primary biliary cirrhosis (PBC)-CREST overlap syndrome with coexistence of Sj\u00f6gren's syndrome and thyroid dysfunction. Clin Rheumatol. 2007, 26:596-600. 10.1007\/s10067-005-0178-x","journal-title":"Clin Rheumatol"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2005.075002","article-title":"Clinical features and prognosis of primary biliary cirrhosis associated with systemic sclerosis","volume":"55","author":"Rigamonti C","year":"2006","unstructured":"Rigamonti C, Shand LM, Feudjo M, Bunn CC, Black CM, Denton CP, Burroughs AK. Clinical features and prognosis of primary biliary cirrhosis associated with systemic sclerosis. Gut. 2006, 55:388-94. 10.1136\/gut.2005.075002","journal-title":"Gut"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2020.10.009","article-title":"Systemic sclerosis overlap and non-overlap syndromes share clinical characteristics but differ in prognosis and treatments","volume":"51","author":"Scherlinger M","year":"2021","unstructured":"Scherlinger M, Lutz J, Galli G, et al.. Systemic sclerosis overlap and non-overlap syndromes share clinical characteristics but differ in prognosis and treatments. Semin Arthritis Rheum. 2021, 51:36-42. 10.1016\/j.semarthrit.2020.10.009","journal-title":"Semin Arthritis Rheum"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1093\/mr\/roab079","article-title":"Epidemiology and clinical characteristics of systemic sclerosis overlap syndrome (SSc-OS), and the factors significantly associated with SSc-OS in Thai patients with systemic sclerosis","volume":"32","author":"Jantarat A","year":"2022","unstructured":"Jantarat A, Muangchan C. Epidemiology and clinical characteristics of systemic sclerosis overlap syndrome (SSc-OS), and the factors significantly associated with SSc-OS in Thai patients with systemic sclerosis. Mod Rheumatol. 2022, 32:899-907. 10.1093\/mr\/roab079","journal-title":"Mod Rheumatol"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinre.2013.04.005","article-title":"Diagnostic and clinical significance of anti-centromere antibodies in primary biliary cirrhosis","volume":"37","author":"Liberal R","year":"2013","unstructured":"Liberal R, Grant CR, Sakkas L, Bizzaro N, Bogdanos DP. Diagnostic and clinical significance of anti-centromere antibodies in primary biliary cirrhosis. Clin Res Hepatol Gastroenterol. 2013, 37:572-85. 10.1016\/j.clinre.2013.04.005","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2014.01.041","article-title":"The diagnosis of primary biliary cirrhosis","volume":"13","author":"Bowlus CL","year":"2014","unstructured":"Bowlus CL, Gershwin ME. The diagnosis of primary biliary cirrhosis. Autoimmun Rev. 2014, 13:441-4. 10.1016\/j.autrev.2014.01.041","journal-title":"Autoimmun Rev"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2014.01.008","article-title":"Manometric assessment of esophageal motor function in patients with primary biliary cirrhosis","volume":"25","author":"Bektas M","year":"2014","unstructured":"Bektas M, Seven G, Idilman R, et al.. Manometric assessment of esophageal motor function in patients with primary biliary cirrhosis. Eur J Intern Med. 2014, 25:230-4. 10.1016\/j.ejim.2014.01.008","journal-title":"Eur J Intern Med"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-021-08918-6","article-title":"The role of autoantibody testing in modern personalized medicine","volume":"63","author":"Kayser C","year":"2022","unstructured":"Kayser C, Dutra LA, Dos Reis-Neto ET, Castro CH, Fritzler MJ, Andrade LE. The role of autoantibody testing in modern personalized medicine. Clin Rev Allergy Immunol. 2022, 63:251-88. 10.1007\/s12016-021-08918-6","journal-title":"Clin Rev Allergy Immunol"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2012.03.001","article-title":"Subgroups of Sj\u00f6gren syndrome patients according to serological profiles","volume":"39","author":"Bournia VK","year":"2012","unstructured":"Bournia VK, Vlachoyiannopoulos PG. Subgroups of Sj\u00f6gren syndrome patients according to serological profiles. J Autoimmun. 2012, 39:15-26. 10.1016\/j.jaut.2012.03.001","journal-title":"J Autoimmun"},{"key":"ref66","article-title":"Reactivity of anti-mitochondrial antibodies in primary biliary cirrhosis and systemic sclerosis","volume":"91","author":"Chou MJ","year":"1992","unstructured":"Chou MJ, Lai MY, Lee SL, Tsay GJ. Reactivity of anti-mitochondrial antibodies in primary biliary cirrhosis and systemic sclerosis. J Formos Med Assoc. 1992, 91:1075-80.","journal-title":"J Formos Med Assoc"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780310310","article-title":"Autoantibodies to mitochondria in systemic sclerosis. Frequency and characterization using recombinant cloned autoantigen","volume":"31","author":"Fregeau DR","year":"1988","unstructured":"Fregeau DR, Leung PS, Coppel RL, McNeilage LJ, Medsger TA Jr, Gershwin ME. Autoantibodies to mitochondria in systemic sclerosis. Frequency and characterization using recombinant cloned autoantigen. Arthritis Rheum. 1988, 31:386-92. 10.1002\/art.1780310310","journal-title":"Arthritis Rheum"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.3109\/08916934.2012.732131","article-title":"Clinical associations of anti-SSA\/Ro60 and anti-Ro52\/TRIM21 antibodies: diagnostic utility of their separate detection","volume":"46","author":"Men\u00e9ndez A","year":"2013","unstructured":"Men\u00e9ndez A, G\u00f3mez J, Escanlar E, Caminal-Montero L, Mozo L. Clinical associations of anti-SSA\/Ro60 and anti-Ro52\/TRIM21 antibodies: diagnostic utility of their separate detection. Autoimmunity. 2013, 46:32-9. 10.3109\/08916934.2012.732131","journal-title":"Autoimmunity"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2009.01.014","article-title":"Is prevalence of PBC underestimated in patients with systemic sclerosis?","volume":"41","author":"Norman GL","year":"2009","unstructured":"Norman GL, Bialek A, Encabo S, et al.. Is prevalence of PBC underestimated in patients with systemic sclerosis?. Dig Liver Dis. 2009, 41:762-4. 10.1016\/j.dld.2009.01.014","journal-title":"Dig Liver Dis"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2015.07.005","article-title":"Immunogenetics of systemic sclerosis: defining heritability, functional variants and shared-autoimmunity pathways","volume":"64","author":"Bossini-Castillo L","year":"2015","unstructured":"Bossini-Castillo L, L\u00f3pez-Isac E, Mart\u00edn J. Immunogenetics of systemic sclerosis: defining heritability, functional variants and shared-autoimmunity pathways. J Autoimmun. 2015, 64:53-65. 10.1016\/j.jaut.2015.07.005","journal-title":"J Autoimmun"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1045523","article-title":"Comprehensive autoantibody profiles in systemic sclerosis: clinical cluster analysis","volume":"13","author":"H\u00f6ppner J","year":"2022","unstructured":"H\u00f6ppner J, Tabeling C, Casteleyn V, et al.. Comprehensive autoantibody profiles in systemic sclerosis: clinical cluster analysis. Front Immunol. 2022, 13:1045523. 10.3389\/fimmu.2022.1045523","journal-title":"Front Immunol"},{"key":"ref72","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780370111","article-title":"Clinical and prognostic associations based on serum antinuclear antibodies in Japanese patients with systemic sclerosis","volume":"37","author":"Kuwana M","year":"1994","unstructured":"Kuwana M, Kaburaki J, Okano Y, Tojo T, Homma M. Clinical and prognostic associations based on serum antinuclear antibodies in Japanese patients with systemic sclerosis. Arthritis Rheum. 1994, 37:75-83. 10.1002\/art.1780370111","journal-title":"Arthritis Rheum"},{"key":"ref73","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-204424","article-title":"2013 classification criteria for systemic sclerosis: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative","volume":"72","author":"van den Hoogen F","year":"2013","unstructured":"van den Hoogen F, Khanna D, Fransen J, et al.. 2013 classification criteria for systemic sclerosis: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative. Ann Rheum Dis. 2013, 72:1747-55. 10.1136\/annrheumdis-2013-204424","journal-title":"Ann Rheum Dis"},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.33696\/\/immunology.2.035","article-title":"Autoantibodies in overlapping systemic sclerosis and primary biliary cirrhosis autoimmune diseases","volume":"2","author":"Valdivia MM","year":"2020","unstructured":"Valdivia MM. Autoantibodies in overlapping systemic sclerosis and primary biliary cirrhosis autoimmune diseases. J Cell Immunol. 2020, 2:165-7. 10.33696\/\/immunology.2.035","journal-title":"J Cell Immunol"},{"key":"ref75","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-006-0465-1","article-title":"A case of limited cutaneous systemic sclerosis developing anti-mitochondria antibody positive primary biliary cirrhosis after acute myocardial infarction","volume":"26","author":"Miyachi K","year":"2007","unstructured":"Miyachi K, Hankins R, Ihara M, et al.. A case of limited cutaneous systemic sclerosis developing anti-mitochondria antibody positive primary biliary cirrhosis after acute myocardial infarction. Clin Rheumatol. 2007, 26:1571-4. 10.1007\/s10067-006-0465-1","journal-title":"Clin Rheumatol"},{"key":"ref76","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-218881","article-title":"Anti-centromere antibodies target centromere-kinetochore macrocomplex: a comprehensive autoantigen profiling","volume":"80","author":"Kajio N","year":"2021","unstructured":"Kajio N, Takeshita M, Suzuki K, et al.. Anti-centromere antibodies target centromere-kinetochore macrocomplex: a comprehensive autoantigen profiling. Ann Rheum Dis. 2021, 80:651-9. 10.1136\/annrheumdis-2020-218881","journal-title":"Ann Rheum Dis"},{"key":"ref77","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejr.2019.04.008","article-title":"Primary biliary cholangitis in patients with systemic sclerosis: unmasking the true face of Reynold\u2019s syndrome","volume":"42","author":"Sarg\u0131n G","year":"2020","unstructured":"Sarg\u0131n G, Senturk T, Borazan S, Coskun A. Primary biliary cholangitis in patients with systemic sclerosis: unmasking the true face of Reynold\u2019s syndrome. Egypt Rheumatol. 2020, 42:31-4. 10.1016\/j.ejr.2019.04.008","journal-title":"Egypt Rheumatol"},{"key":"ref78","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2021.105236","article-title":"Coexistence of immune-mediated diseases in sarcoidosis. Frequency and clinical significance in 1737 patients","volume":"88","author":"Brito-Zer\u00f3n P","year":"2021","unstructured":"Brito-Zer\u00f3n P, P\u00e9rez-Alvarez R, Feijoo-Mass\u00f3 C, et al.. Coexistence of immune-mediated diseases in sarcoidosis. Frequency and clinical significance in 1737 patients. Joint Bone Spine. 2021, 88:105236. 10.1016\/j.jbspin.2021.105236","journal-title":"Joint Bone Spine"},{"key":"ref79","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185X.14103","article-title":"Association of serum CCL20 levels with pulmonary vascular involvement and primary biliary cholangitis in patients with systemic sclerosis","volume":"24","author":"Ikawa T","year":"2021","unstructured":"Ikawa T, Miyagawa T, Fukui Y, et al.. Association of serum CCL20 levels with pulmonary vascular involvement and primary biliary cholangitis in patients with systemic sclerosis. Int J Rheum Dis. 2021, 24:711-8. 10.1111\/1756-185X.14103","journal-title":"Int J Rheum Dis"},{"key":"ref80","doi-asserted-by":"publisher","DOI":"10.1007\/BF00918090","article-title":"Antimitochondrial (pyruvate dehydrogenase) autoantibodies in autoimmune rheumatic diseases","volume":"12","author":"Zurgil N","year":"1992","unstructured":"Zurgil N, Bakimer R, Moutsopoulos HM, et al.. Antimitochondrial (pyruvate dehydrogenase) autoantibodies in autoimmune rheumatic diseases. J Clin Immunol. 1992, 12:201-9. 10.1007\/BF00918090","journal-title":"J Clin Immunol"},{"key":"ref81","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780380715","article-title":"Autoantibodies to pyruvate dehydrogenase complex in patients with systemic sclerosis. Possible role of anti-E1 alpha antibody as a serologic indicator for development of primary biliary cirrhosis","volume":"38","author":"Fujimoto M","year":"1995","unstructured":"Fujimoto M, Sato S, Ihn H, Kikuchi K, Tamaki K, Takehara K. Autoantibodies to pyruvate dehydrogenase complex in patients with systemic sclerosis. Possible role of anti-E1 alpha antibody as a serologic indicator for development of primary biliary cirrhosis. Arthritis Rheum. 1995, 38:985-9. 10.1002\/art.1780380715","journal-title":"Arthritis Rheum"},{"key":"ref82","article-title":"Diagnosis and treatment of primary biliary cirrhosis","volume":"6","author":"Nishio A","year":"2000","unstructured":"Nishio A, Keeffe EB, Ishibashi H, Gershwin EM. Diagnosis and treatment of primary biliary cirrhosis. Med Sci Monit. 2000, 6:181-93.","journal-title":"Med Sci Monit"},{"key":"ref83","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-021-08904-y","article-title":"Antimitochondrial antibodies: from bench to bedside","volume":"63","author":"Colapietro F","year":"2022","unstructured":"Colapietro F, Lleo A, Generali E. Antimitochondrial antibodies: from bench to bedside. Clin Rev Allergy Immunol. 2022, 63:166-77. 10.1007\/s12016-021-08904-y","journal-title":"Clin Rev Allergy Immunol"},{"key":"ref84","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2024.01.030","article-title":"Treatment in primary biliary cholangitis: beyond ursodeoxycholic acid","volume":"124","author":"van Hooff MC","year":"2024","unstructured":"van Hooff MC, Werner E, van der Meer AJ. Treatment in primary biliary cholangitis: beyond ursodeoxycholic acid. Eur J Intern Med. 2024, 124:14-21. 10.1016\/j.ejim.2024.01.030","journal-title":"Eur J Intern Med"},{"key":"ref85","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005526.pub2","article-title":"Cyclosporin A for primary biliary cirrhosis","volume":"2007","author":"Gong Y","year":"2007","unstructured":"Gong Y, Christensen E, Gluud C. Cyclosporin A for primary biliary cirrhosis. Cochrane Database Syst Rev. 2007, 2007:CD005526. 10.1002\/14651858.CD005526.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"ref86","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2312100","article-title":"A phase 3 trial of seladelpar in primary biliary cholangitis","volume":"390","author":"Hirschfield GM","year":"2024","unstructured":"Hirschfield GM, Bowlus CL, Mayo MJ, et al.. A phase 3 trial of seladelpar in primary biliary cholangitis. N Engl J Med. 2024, 390:783-94. 10.1056\/NEJMoa2312100","journal-title":"N Engl J Med"},{"key":"ref87","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2306185","article-title":"Efficacy and safety of elafibranor in primary biliary cholangitis","volume":"390","author":"Kowdley KV","year":"2024","unstructured":"Kowdley KV, Bowlus CL, Levy C, et al.. Efficacy and safety of elafibranor in primary biliary cholangitis. N Engl J Med. 2024, 390:795-805. 10.1056\/NEJMoa2306185","journal-title":"N Engl J Med"},{"key":"ref88","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-023-00909-5","article-title":"State-of-the-art evidence in the treatment of systemic sclerosis","volume":"19","author":"Pope JE","year":"2023","unstructured":"Pope JE, Denton CP, Johnson SR, Fernandez-Codina A, Hudson M, Nevskaya T. State-of-the-art evidence in the treatment of systemic sclerosis. Nat Rev Rheumatol. 2023, 19:212-26. 10.1038\/s41584-023-00909-5","journal-title":"Nat Rev Rheumatol"},{"key":"ref89","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2024-226430","article-title":"EULAR recommendations for the treatment of systemic sclerosis: 2023 update","volume":"84","author":"Del Galdo F","year":"2025","unstructured":"Del Galdo F, Lescoat A, Conaghan PG, et al.. EULAR recommendations for the treatment of systemic sclerosis: 2023 update. Ann Rheum Dis. 2025, 84:29-40. 10.1136\/ard-2024-226430","journal-title":"Ann Rheum Dis"},{"key":"ref90","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1903076","article-title":"Nintedanib for systemic sclerosis-associated interstitial lung disease","volume":"380","author":"Distler O","year":"2019","unstructured":"Distler O, Highland KB, Gahlemann M, et al.. Nintedanib for systemic sclerosis-associated interstitial lung disease. N Engl J Med. 2019, 380:2518-28. 10.1056\/NEJMoa1903076","journal-title":"N Engl J Med"},{"key":"ref91","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2020.102510","article-title":"The roles of PPAR\u03b3 and its agonists in autoimmune diseases: a comprehensive review","volume":"113","author":"Liu Y","year":"2020","unstructured":"Liu Y, Wang J, Luo S, Zhan Y, Lu Q. The roles of PPAR\u03b3 and its agonists in autoimmune diseases: a comprehensive review. J Autoimmun. 2020, 113:102510. 10.1016\/j.jaut.2020.102510","journal-title":"J Autoimmun"},{"key":"ref92","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/549107","article-title":"Current concepts: mouse models of Sj\u00f6gren's syndrome","volume":"2011","author":"Lavoie TN","year":"2011","unstructured":"Lavoie TN, Lee BH, Nguyen CQ. Current concepts: mouse models of Sj\u00f6gren's syndrome. J Biomed Biotechnol. 2011, 2011:549107. 10.1155\/2011\/549107","journal-title":"J Biomed Biotechnol"},{"key":"ref93","doi-asserted-by":"publisher","DOI":"10.1016\/j.hbpd.2022.05.009","article-title":"Concomitant extrahepatic autoimmune diseases do not compromise the long-term outcomes of primary biliary cholangitis","volume":"21","author":"Chen S","year":"2022","unstructured":"Chen S, Li MQ, Duan WJ, et al.. Concomitant extrahepatic autoimmune diseases do not compromise the long-term outcomes of primary biliary cholangitis. Hepatobiliary Pancreat Dis Int. 2022, 21:577-82. 10.1016\/j.hbpd.2022.05.009","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"ref94","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0298225","article-title":"Genetic link between primary biliary cholangitis and connective tissue diseases in European populations: a two-sample Mendelian randomization study","volume":"19","author":"Liu Z","year":"2024","unstructured":"Liu Z, Shao Y, Duan X. Genetic link between primary biliary cholangitis and connective tissue diseases in European populations: a two-sample Mendelian randomization study. PLoS One. 2024, 19:e0298225. 10.1371\/journal.pone.0298225","journal-title":"PLoS One"},{"key":"ref95","doi-asserted-by":"publisher","DOI":"10.4254\/wjh.v12.i12.1158","article-title":"Spectrum of esophageal motility disorders in patients with liver cirrhosis","volume":"12","author":"Khalaf M","year":"2020","unstructured":"Khalaf M, Castell D, Elias PS. Spectrum of esophageal motility disorders in patients with liver cirrhosis. World J Hepatol. 2020, 12:1158-67. 10.4254\/wjh.v12.i12.1158","journal-title":"World J Hepatol"},{"key":"ref96","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2022.103167","article-title":"Standardized incidence ratios and risk factors for cancer in patients with systemic sclerosis: data from the Spanish Scleroderma Registry (RESCLE)","volume":"21","author":"Carbonell C","year":"2022","unstructured":"Carbonell C, Marcos M, Guill\u00e9n-Del-Castillo A, et al.. Standardized incidence ratios and risk factors for cancer in patients with systemic sclerosis: data from the Spanish Scleroderma Registry (RESCLE). Autoimmun Rev. 2022, 21:103167. 10.1016\/j.autrev.2022.103167","journal-title":"Autoimmun Rev"},{"key":"ref97","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.49.3640","article-title":"Acute right heart failure and achalasia-like syndrome in a patient with limited cutaneous systemic sclerosis and primary biliary cirrhosis","volume":"49","author":"Nomoto T","year":"2010","unstructured":"Nomoto T, Kikuchi T, Kusunoki Y, Akesaka K, Yano K, Fujii Y, Makino H. Acute right heart failure and achalasia-like syndrome in a patient with limited cutaneous systemic sclerosis and primary biliary cirrhosis. Intern Med. 2010, 49:1779-82. 10.2169\/internalmedicine.49.3640","journal-title":"Intern Med"},{"key":"ref98","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2013.01.010","article-title":"The critical importance of epigenetics in autoimmunity","volume":"41","author":"Lu Q","year":"2013","unstructured":"Lu Q. The critical importance of epigenetics in autoimmunity. J Autoimmun. 2013, 41:1-5. 10.1016\/j.jaut.2013.01.010","journal-title":"J Autoimmun"},{"key":"ref99","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtauto.2022.100141","article-title":"Autoantibodies in the disease criteria for systemic sclerosis: the need for specification for optimal application","volume":"5","author":"Damoiseaux J","year":"2022","unstructured":"Damoiseaux J, Potjewijd J, Smeets RL, Bonroy C. Autoantibodies in the disease criteria for systemic sclerosis: the need for specification for optimal application. J Transl Autoimmun. 2022, 5:100141. 10.1016\/j.jtauto.2022.100141","journal-title":"J Transl Autoimmun"},{"key":"ref100","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2249.1998.00735.x","article-title":"Antibody to carbonic anhydrase II is present in primary biliary cirrhosis (PBC) irrespective of antimitochondrial antibody status","volume":"114","author":"Invernizzi P","year":"1998","unstructured":"Invernizzi P, Battezzati PM, Crosignani A, et al.. Antibody to carbonic anhydrase II is present in primary biliary cirrhosis (PBC) irrespective of antimitochondrial antibody status. Clin Exp Immunol. 1998, 114:448-54. 10.1046\/j.1365-2249.1998.00735.x","journal-title":"Clin Exp Immunol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/348033-systemic-sclerosis-and-primary-biliary-cholangitis-a-comprehensive-review-of-two-overlapping-rare-entities-with-insights-on-diagnostics-and-management","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T14:02:32Z","timestamp":1744293752000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/348033-systemic-sclerosis-and-primary-biliary-cholangitis-a-comprehensive-review-of-two-overlapping-rare-entities-with-insights-on-diagnostics-and-management"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,10]]},"references-count":100,"URL":"https:\/\/doi.org\/10.7759\/cureus.82008","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4,10]]}}}